NEW YORK (GenomeWeb News) – Celera subsidiary Berkeley HeartLab said yesterday that Geisinger Medical Center and a clinical lab service recently started by Geisinger Health System will use some of its cardiovascular diagnostic tests and services.

Under a co-marketing agreement, Geisinger Health System's Proven Diagnostics lab service will provide BHL's 4myheart cardiovascular disease management program and select tools from BHL's menu of cardiovascular tests and services. Proven Diagnostics and Geisinger Medical Center also will have access to BHL's KIF6 test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.